KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

BeOne Medicines (ONC) Return on Invested Capital: 2017-2025

Historic Return on Invested Capital for BeOne Medicines (ONC) over the last 2 years, with Sep 2025 value amounting to 0.02%.

  • BeOne Medicines' Return on Invested Capital was N/A to 0.02% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.02%, marking a year-over-year change of. This contributed to the annual value of -0.55% for FY2018, which is N/A change from last year.
  • According to the latest figures from Q3 2025, BeOne Medicines' Return on Invested Capital is 0.02%, which was up 112.02% from -0.13% recorded in Q4 2021.
  • BeOne Medicines' Return on Invested Capital's 5-year high stood at 0.02% during Q3 2025, with a 5-year trough of -0.13% in Q4 2021.
  • Over the past 1 years, BeOne Medicines' median Return on Invested Capital value was 0.02% (recorded in 2025), while the average stood at 0.02%.